626 Bancroft Way Suite A


Developer of a healthcare technology designed to provide 3D illustration of bacteria which causes tuberculosis. The company’s technology provides central lab quantitative immunoassay in less than an hour compared to the clinical testing and patient self-reporting, enabling caregivers to make clear tuberculosis treatment decisions through objective guidance.